LifeMine Therapeutics
Founded 2016 · CIK 0001686955 · Biotech · Private
Small molecule therapeutics synthesized from fungal genomic data
lifeminetx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $30M
- 2 Form D · Sep 2017
- 108 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 39
- 2 granted · 37 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,000,500 | |
| Private capital raised | Form D · SEC | $25,074,131 |
Form D · SECPress
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2343 | INFIXION BIOSCIENCE, INC. | — | — |
| 2344 | BioLeap, Inc. | — | $5.0M |
| 2345 | GENOPLAN INC. | — | $4.2M |
| 2346 | LifeMine Therapeutics | — | $30M |
| 2347 | MEDICON, INC. | — | — |
| 2348 | THYMMUNE THERAPEUTICS INC | — | — |
| 2349 | OmniTier, Inc. | — | $4.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Press
‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series EFierceBiotech
Founders & Team
- Yanling CaoDirector
- Hingge HsuDirector · Executive Officer
- Edward HuDirector
- Richard KlausnerDirector
- Wei LiDirector
- Jim TananbaumDirector
- Gregory VerdineDirector · Executive Officer
- Krishna YeshwantDirector
- Weiqing ZhouDirector · Executive Officer
Patents
- Novel Cyclodepsipeptides And Cyclopeptides And Their Use In Therapyapplication
- Human Therapeutic Targets and Modulators Thereofapplication
- Triester Compounds And Methods Of Use Thereofapplication
- Methods And Systems For Discovery Of Non-Embedded Target Genesapplication
- Human Therapeutic Targets And Modulators Thereofgranted
- Methods and Systems for Discovery of Embedded Target Genes in Biosynthetic Gene Clustersapplication
- Deep Learning Methods For Biosynthetic Gene Cluster Discoveryapplication
- Computational Method To Identify Gene Networks Containing Functionally-Related Genesapplication
- Methods And Systems For Identifying Genes Associated With Biosynthetic Gene Clustersapplication
- Compounds, Compositions, And Methods Of Treatment Thereofapplication
- Human Therapeutic Targets And Modulators Thereofgranted
- Triester Compounds And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.